Clinical trial · Interventional
An Online Cognitive Assessment in Cancer Patients
Phase II SBIR - CAMPFIRE: An Electronic Platform for Cognitive Assessment in Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to test the feasibility (acceptability and usability) and usefulness of the CAMPFIRE (Cognitive Assessment and Monitoring Platform for Integrative Research) system, a patient-facing portal able to collect and produce reports for clinicians on Patient Reported Outcome Measurement Information System (PROMIS-Cognitive Function/Anxiety/Depression) outcomes via MyChart and NIH Toolbox, an inperson brief objective cognitive function battery. This study will aim to determine the value of the CAMPFIRE system for patients and providers as a tool for monitoring cognitive symptoms throughout the course of chemotherapy
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer-Related Cognitive Difficulties | — | UNRESOLVED | — |
| Cancer-Related Cognitive Impairment | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CAMPFIRE Online Cognitive Assessment for Cancer Patients | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- CAMPFIRE Assessment
- description
- NIH Toolbox Cognitive Assessment and PROMIS Surveys
- interventionNames
- Behavioral: CAMPFIRE Online Cognitive Assessment for Cancer Patients
Primary outcomes (1)
- measure
- Completion
- timeFrame
- Post-Chemotherapy (16-18 weeks)
- description
- To determine the proportion of patients who complete the full-scope CAMPFIRE NIH PROMIS and NIH Toolbox battery throughout treatment (i.e., pre-chemotherapy time-point, 6-9 week time-point, post-chemotherapy time-point) Among the enrolled patients we will calculate proportions of patients who complete the full CAMPFIRE workflow at multiple time points: (1) at pre-chemotherapy; (2) at post-chemotherapy; and (3) at any time point in between. Similarly, proportions of completers will be calculated for each collection of measures for CAMPFIRE (NIH PROMIS and NIH Toolbox). The differences in completion of tests by age and gender will be compared. For individual tests, we will determine the proportion of patients completing the test and use descriptive statistics to summarize data. Descriptive statistics will be used to characterize the cohort of enrolled patients.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Must have diagnosis of cancer * Must be scheduled to receive any standard course of curative intent cytotoxic chemotherapy * Must have a computer, a general knowledge of how to use a computer and access to the internet * Must be able to speak and read English * Must be 21 years or older * Must provide informed consent Exclusion Criteria: * Must not be currently hospitalized or have been hospitalized for any psychiatric illness within the last year * Must not be diagnosed with neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease) * Must not have any CNS disease (e.g., movement disorder, multiple sclerosis)
References
Publications (0)
Data not yet available